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activity but very little p22phox or iNOS expressions. 
Active inflammatory demyelinating lesions induced by 
CD8+ T cells or by innate immunity showed macrophage 
and microglial activation together with the expression of 
p22phox, but low or absent iNOS reactivity. We corrobo-
rated the differences between acute CD4+ T cell-mediated 
experimental autoimmune encephalomyelitis and acute 
MS lesions via gene expression studies. Furthermore, age-
dependent iron accumulation and lesion-associated iron lib-
eration, as occurring in the human brain, were only minor 
in rodent brains. Our study shows that oxidative injury and 
its triggering mechanisms diverge in different models of 
rodent central nervous system inflammation. The amplifica-
tion of oxidative injury, which has been suggested in MS, 
is only reflected to a limited degree in the studied rodent 
models.
Keywords Multiple sclerosis · experimental autoimmune 
encephalomyelitis (eAe) · Oxidative injury · NADPH 
oxidase · Inducible nitric oxide synthase (iNOS) · Iron
Abstract recent data suggest that oxidative injury may 
play an important role in demyelination and neurodegen-
eration in multiple sclerosis (MS). We compared the extent 
of oxidative injury in MS lesions with that in experimental 
models driven by different inflammatory mechanisms. It 
was only in a model of coronavirus-induced demyelinat-
ing encephalomyelitis that we detected an accumulation of 
oxidised phospholipids, which was comparable in extent to 
that in MS. In both, MS and coronavirus-induced encepha-
lomyelitis, this was associated with massive microglial and 
macrophage activation, accompanied by the expression 
of the NADPH oxidase subunit p22phox but only sparse 
expression of inducible nitric oxide synthase (iNOS). 
Acute and chronic CD4+ T cell-mediated experimental 
autoimmune encephalomyelitis lesions showed transient 
expression of p22phox and iNOS associated with inflam-
mation. Macrophages in chronic lesions of antibody-medi-
ated demyelinating encephalomyelitis showed lysosomal 
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Introduction
Multiple sclerosis (MS) is a chronic inflammatory dis-
ease of the central nervous system (CNS) leading to 
focal plaques of primary demyelination in the white and 
grey matter, with astrocytic scar formation and profound 
axonal and neuronal degeneration [46]. recent studies, 
including the same cases of autopsy tissue as the current 
study, suggest that oxidative injury may play a major role 
in the pathogenesis of MS [47]. In active lesions of the 
white matter and the cerebral cortex, demyelination and 
neurodegeneration were associated with the presence of 
oxidised lipids (oxidised phospholipids and malonedial-
dehyde) in myelin, apoptotic oligodendrocytes [33] and 
degenerating axons and neurons [26, 33]. Furthermore, 
nuclei of degenerating glia cells and neurons contained 
oxidised DNA [33]. Oxidative injury was associated with 
inflammation and oxidative burst in activated microglia 
and macrophages expressing p22phox as an essential sub-
unit of NADPH oxidases [25, 26]. Mitochondrial injury 
[11, 54] as well as accumulation of iron in the ageing 
brain and its liberation from intracellular stores in active 
MS lesions [35] was suggested to further amplify the oxi-
dative injury.
experimental autoimmune encephalomyelitis (eAe) is 
currently the most widely used model of MS-like inflam-
matory demyelination in the CNS [30]. Many recent 
studies have used this model to unravel molecular mech-
anisms involved in inflammation, demyelination and 
neurodegeneration. This served as the basis for currently 
established anti-inflammatory treatments of the disease 
[95], but the success in developing neuroprotective thera-
pies has so far been limited. This is particularly the case 
for progressive MS, for which currently no treatment is 
available [32, 47]. The production and release of reactive 
oxygen and nitric oxide species have been shown to play 
a role in the pathogenesis of tissue injury in eAe [62, 
78]. Whether the nature and extent of oxidative injury 
in rodent models of inflammatory demyelinating dis-
eases are comparable to that observed in MS is currently 
unresolved. We, thus, analysed a large sample of acute 
and chronic experimental inflammatory brain diseases, 
including classical CD4+ T cell-driven models of eAe, 
brain inflammation induced by MHC class I-restricted 
cytotoxic T cells, by innate immunity or by virus infec-
tion in direct comparison with MS lesions. relying on 
identical tools as used for MS lesions, we found that 
inflammation-induced oxidative burst was only in part 
similar in experimental rodent models and MS. Further-
more, accumulation of oxidised phospholipids, which is 
associated with demyelination and neurodegeneration 
in MS lesions, was only observed in a model of virus-
induced inflammatory demyelination.
Our data suggest that the mechanisms of tissue injury 
in MS are only incompletely reflected in the investigated 
rodent models and that new models will be necessary for 
the development and testing of neuroprotective therapy 
strategies intended to target oxidative injury.
Materials and methods
MS patients and experimental models
Our study was performed on archival formalin-fixed paraf-
fin-embedded tissue of MS patients and on archival mate-
rial derived from experimental animal models of brain 
inflammation and demyelination collected at the Centre for 
Brain research during the last three decades. The study was 
approved by the ethical Committee of the Medical Univer-
sity of Vienna (eK. Nos. 535/2004 and 213/06/2013). The 
MS study cohort contained autopsy tissue from 17 controls 
and 31 MS cases, including 7 patients with acute MS, 3 
patients with relapsing remitting MS (rrMS), 12 patients 
with secondary progressive MS (SPMS) and 9 patients with 
primary progressive MS (PPMS). The corresponding clini-
cal data were already described in detail elsewhere [35]. 
Details on the sample of human autopsy cases and the basic 
pathology are provided in the supplementary data.
For the analysis of experimental models, we used rat 
and mouse tissues from former studies performed in col-
laboration with our laboratory. The different study designs 
and the pathological characterisation of the tissues have 
been described in detail in the respective previous publi-
cations [1, 21, 44, 80, 85, 87, 92, 97]. Tissue blocks con-
taining inflammatory lesions with active demyelination or 
neurodegeneration defined by the presence of macrophages 
with early myelin or neuronal degradation products were 
selected from a large collection. The following experimen-
tal models were analysed: acute eAe triggered by passive 
transfer of myelin basic protein reactive CD4+ T cells [1], 
chronic eAe induced in mice by active sensitisation with 
MOg35–55 peptide [87], chronic relapsing eAe induced 
in DA rats by active sensitisation with MOg1–125 [85], 
acute eAe induced by passive transfer of encephalitogenic 
CD8+ T cells [80], inflammatory demyelination induced by 
intraspinal injection of lipopolysaccharide [21, 56], demy-
elinating lesions induced in mice by cuprizone diet [92] 
and chronic inflammatory demyelinating disease follow-
ing mouse hepatitis virus strain JHM (MHV-JHM) corona-
virus infection [3, 44, 94, 97]. Details on the experimental 
designs, clinical course and neuropathological alterations 
as well as animal numbers and time points of investigation 
for this study are provided in the supplementary data. For 
control reasons, brain, spinal cord and lymphatic tissues of 
young and aged lewis rats, SD rats (untreated and saline 
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injected), DA rats and C57BL/6 mice without inflammatory 
lesions were analysed.
experimental material was routinely fixed in 4 % par-
aformaldehyde (PFA) and embedded in paraffin. Basic 
neuropathological evaluation was based on haematoxylin/
eosin staining, luxol Fast Blue myelin stain and Biels-
chowsky silver impregnation. Inflammation was detected 
by immunohistochemistry for CD3. Macrophage activa-
tion was studied using antibodies against Iba-1 (human, rat 
and mouse tissues), CD68 (human), eD1 (rat) and Mac-3 
(mouse). Active demyelination was assessed by immuno-
histochemistry for myelin basic protein (MBP), myelin oli-
godendrocyte glycoprotein (MOg) and proteolipid protein 
(PlP). For the detection of oxidative injury, the following 
markers were used: e06 (recognising oxidised phospho-
lipids), MDA2 (malonedialdehyde), 8OHdg (8-hydroxy-2 
deoxyguanosine), p22phox (subunit of NADPH oxidase 
complexes), iNOS (Nos2; inducible nitric oxide synthase) 
and 3,3′-diaminobenzidine (DAB)-enhanced Turnbull blue 
reaction (non-haeme tissue iron). A detailed validation of 
the applied techniques showed suitability, comparable 
sensitivity and specificity in studies using rat, mouse and 
human material (Supplementary Figs. 1 and 2).
Immunohistochemistry
Sections were cut (5 μm), routinely deparaffinised and 
rehydrated. endogenous peroxidase activity was blocked 
in methanol with 0.02 % hydrogen peroxide (H2O2) for 
30 min. Antigen retrieval procedures and primary anti-
bodies are listed in Table 1. Prior to staining, non-specific 
antibody binding was blocked by incubating the sections 
with 10 % foetal calf serum (FCS) in Dako buffer (Dako). 
Primary antibodies were applied in 10 % FCS/Dako buffer 
at 4 °C overnight. Secondary antibodies were applied for 
1 h at room temperature (rT) in 10 % FCS/Dako buffer. 
Finally, the sections were incubated with avidin peroxidase 
(1:100, Sigma Aldrich) in 10 % FCS/Dako buffer for 1 h at 
rT. Antibody binding was routinely visualised using DAB 
(Sigma Aldrich). The sections were counterstained with 
haematoxylin, dehydrated and mounted in eukitt.
For double labelling of e06 and TPPP/p25 for oligo-
dendrocytes or gFAP for astrocytes, e06 primary antibody 
was applied, followed by alkaline phosphatase-conjugated 
anti-mouse secondary antibody (1:200, Jackson Immu-
noresearch) incubation and fast blue development (blue 
reaction product). Subsequently, the sections were steamed 
Table 1  Primary antibodies and antigen retrieval procedures
Antibodies were used for human, rat and mouse tissues with the following exceptions: CD68 for human, eD1 and Ox8 for rat, Mac-3 for mouse 
tissue and iNOS anti-rat for rat and mouse
0 no antigen retrieval, St steaming using the indicated buffer for 1 h, C citrate buffer (pH 6.0), E eDTA buffer (pH 8.6), mAb monoclonal anti-
body, pAb polyclonal antibody
Antibody Origin Target Dilution Antigen retrieval Source
8OHdg goat (pAB) 8-Hydroxy-2′-deoxyguanosine 1:500 St (e) Abcam; ab10802
APP Mouse (mAb) Amyloid precursor protein 1:1000 St (C) Chemicon; MAB348
CD3 rabbit (mAb) T cells 1:2000 St (e) Neomarkers; rM-9107
CD68 Mouse (mAb) Phagocytic macrophages 1:100 St (e) Dako; M0814
e06 Mouse (mAb) Oxidised phospholipids 1:200 0 Avanti; 330001
eD1 Mouse (mAb) rat CD68 1:1000 St (e) Serotec; MCA341r
gFAP rabbit (pAB) glial fibrillary acidic protein 1:3000 St (e) Dako; Z0334
Iba-1 rabbit (pAb) Ionised calcium binding adaptor  
molecule 1
1:3000 St (e) Wako chemicals; 019-19741
iNOS anti-human rabbit (pAb) Inducible nitric oxide synthase 1:30000 St (e) Chemicon; AB5384
iNOS anti-rat rabbit (pAb) Inducible nitric oxide synthase 1:375 St (C) Chemicon; AB1631
Mac-3 rat (pAb) Mouse CD68 1:200 St (C) Serotec; MCA2293FB
MBP rabbit (pAb) Myelin basic protein 1:2500 0 Dako; A0623
MDA2 Mouse (mAB) Malonedialdehyde-lysine 1:1000 St (e) Palinski et al. [64]
MOg Y10 and Z12 Mouse (mABs) Myelin oligodendrocyte glycoprotein 1:100 St (C) Piddlesten et al. [71]
N 556 Mouse (mAb) Virus nucleocapsid 1:50 0 Wege et al. [93]
Ox8 Mouse (mAb) Anti-rat CD8 1:400 0 Seralab; MAS041
p22phox rabbit (pAb) NADPH oxidase protein 1:100 St (C) Santa Cruz Biotech; sc-20781
PlP Mouse (mAB) Proteolipid protein 1:1000 St (e) Serotec; MCA839g
TPPP/p25 rat (pAB) Tubulin polymerisation  
promoting protein
1:3000 St (e) Hoftberger et al. [38]
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in eDTA buffer followed by TPPP/p25 or gFAP primary 
antibody application, species-specific biotinylated anti-rat 
(1:1,500, Jackson Immunoresearch) or anti-rabbit anti-
body (1:2,000, Jackson Immunoresearch), avidin-peroxi-
dase incubation and development in amino ethylcarbazole 
reagent (red reaction product, for details see [33, 56]). In 
case of e06 double staining with APP, e06 primary anti-
body incubation was followed by alkaline phosphatase-
conjugated anti-mouse secondary antibody and fast blue 
development. Subsequently, the sections were steamed in 
citrate buffer, followed by APP primary antibody appli-
cation, biotinylated secondary antibody (1:500, Jackson 
Immunoresearch) and avidin-peroxidase incubation and 
amino ethylcarbazole development. Double labelling of 
Ox8 and eD1 was performed starting with eD1 primary 
antibody application, biotinylated secondary antibody and 
avidin-peroxidase incubation and DAB development. Sub-
sequently, the sections were incubated with Ox8 primary 
antibody which was followed by alkaline phosphatase-
conjugated anti-mouse secondary antibody and fast blue 
development.
Quantification of immunohistochemistry was performed 
by manual counting of CD3+ T cells or APP+ axonal sphe-
roids. eD1+, Iba-1+, p22phox+, iNOS+ or iron-positive 
macrophages and microglia were quantified by densitomet-
ric analysis of pictures taken under standardised conditions 
(identical microscope settings controlled by white balance 
values) with a reichert Polyvar 2 microscope using Nikon 
NIS-elements D3.10. Pictures were captured with gain 
1.2 and an exposure time of 6 ms. Area fraction was deter-
mined using ImageJ. The stainings were quantified from 
equally sized regions of interest in all cases.
Histochemistry for non-haeme tissue iron
The DAB-enhanced Turnbull blue staining (TBB) proto-
col was applied as described [57]. Briefly, paraffin sections 
were routinely deparaffinised and incubated in ammonium 
sulphide (2 % in distilled water; Merck) for 90 min. After 
thorough washing, the sections were treated with an aque-
ous solution of 10 % potassium ferricyanide (Merck) in 
0.5 % HCl. endogenous peroxidase was blocked in meth-
anol with 0.01 M sodium azide and 0.3 % hydrogen per-
oxide for 60 min. Tissue iron was visualised by a 20-min 
incubation in 0.025 % DAB and 0.0005 % H2O2 in 0.1 M 
phosphate buffer.
Densitometric quantification of iron and e06 stainings
Pictures were taken from slides stained for iron or e06 
under standardised conditions as described above. Optical 
density was determined by ImageJ after converting the pic-
tures to 8-bit, inverting and setting the scale to 1,024 = 1.
Whole-genome microarray analysis of human MS samples
Data have been deposited in NCBI’s gene expression 
Omnibus (geO Accession Number gSe32915). A com-
prehensive description of technical issues [25] and clini-
cal data of the study cohort [35] have been published pre-
viously. Shortly summarised, the rNA quality of archival 
formalin-fixed paraffin-embedded tissue blocks contain-
ing white matter brain lesions from acute MS or control 
patients was determined by in situ hybridisation for PlP 
mrNA [8]. If a strong hybridisation signal within oligo-
dendrocytes was detected after a short development time, 
consecutive 6–10 μm sections were mounted on glass 
slides. Areas containing either periplaque white matter (3 
cases), initial (pre-phagocytic) lesions (4 different lesions 
from 3 cases) [4, 56] or active lesions containing early 
myelin degradation products (5 different lesions from 4 
cases) [10] were microdissected. likewise, normal white 
matter material from four control cases was collected. Total 
rNA was isolated using the High Pure FFPe rNA Micro 
Kit (roche). Subsequently, two amplification rounds were 
run using oligo(dT) primers and the Arcturus® Paradise® 
FFPe Amplification Kit (Applied Biosystems® life Tech-
nology™). rNA labelling, hybridisation to Agilent whole-
genome microarrays (4 × 44 K), microarray scanning as 
well as quantile normalisation of the raw data was carried 
out by Source BioScience imagenes gmbH. For data anal-
ysis, relative quantities (rQ) were calculated for each indi-
vidual gene by comparing the mean values of periplaque 
white matter, initial lesion and active lesion with the mean 
value of the NWM from controls. Various technical issues, 
for example problems due to formalin fixation-induced 
rNA strand breaks, issues of data validation and compa-
rability with rT-qPCr data were extensively discussed in 
previous publications [25, 26]. A detailed description of 
gene and probe specifications is provided in Supplementary 
Table 3.
TaqMan® rT-qPCr gene expression analysis of rat eAe 
tissue
lewis rats, either 4- or 8-month old, were injected intra-
peritoneally with MBP-specific T cells to trigger eAe. At 
the peak of disease (day 6) as well as during the recov-
ery phase (day 10), 3 rats per age group were euthanized 
by inhalation of an overdose of CO2. For control reasons, 
3 uninjected rats per age group were included. The ani-
mals were subsequently perfused with ice-cold PBS and 
the lumbar spinal cord was sampled, snap-frozen and 
kept at −20 °C for short-term storage. rNA was rou-
tinely isolated from 40 mg tissue using the peqgOlD 
Total rNA Kit and peqgOlD DNase I Digest Kit (Peqlab 
Biotechnologie gmbH). rNA quantity and purity were 
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determined spectrophotometrically (Nanodrop 2000; 
Peqlab Biotechnologie gmbH). Assessment of rNA qual-
ity was performed on a 2100 Bioanalyzer (Agilent Tech-
nologies Inc). With a mean rNA integrity number of 7.7 
(±0.6), all samples were qualified for further processing. 
Using the High Capacity cDNA reverse Transcription Kit 
(Applied Biosystems® life Technologies™), 500 ng total 
rNA in a final reaction volume of 20 μl was transcribed 
into cDNA employing the following thermal cycling 
conditions: 10 min at 25 °C; 120 min at 37 °C; 5 min at 
85 °C. Thereof, 400 ng rNA equivalents per sample were 
mixed together with appropriate amounts of TaqMan® 
gene expression Master Mix (Applied Biosystems® life 
Technologies™) and loaded into each reservoir of Cus-
tom 384-Well Microfluidic Card TaqMan® gene expres-
sion Arrays (Applied Biosystems® life Technologies™). 
According to the manufacturer’s instructions, the micro-
fluidic cards were centrifuged, sealed and subsequently 
run on a 7900HT Fast real-Time PCr System employ-
ing SDS Software v2.4 (Applied Biosystems® life Tech-
nologies™) and the following thermal cycling conditions: 
2 min at 50 °C; 10 min at 94.5 °C; 40 cycles alternating 
30 s at 97 °C and 1 min at 59.7 °C.
Data were analysed using expressionSuite Software 
v1.0.3 (Applied Biosystems® life Technologies™). Base-
line and threshold settings were manually adjusted for each 
individual gene. The comparative CT (ΔΔCT) method was 
used to calculate relative quantities (rQ). Normalisation 
of CT values was based on five reference genes (18sRNA, 
X03205; Gapdh, NM_017008; Hprt1, NM_012583; Pgk1, 
NM_053291; Ppia, NM_017101). A detailed description of 
gene and TaqMan® array specifications is provided in Sup-
plementary Table 4.
Statistical analysis
Descriptive statistics included median value and range, 
box plots and scatter plots. The linear dependence of sam-
ples was evaluated by Pearson correlation test. For com-
parison of multiple groups of normally distributed data 
one-way ANOVA followed by pair-wise comparisons and 
Tukey adjustment were calculated. In case of multiple 
comparison of not normally distributed data derived from 
densitometry, Kruskal–Wallis group testing was followed 
by Mann–Whitney U post hoc tests and Bonferroni–Holm 
correction. Active lesions of experimental models were 
compared with the corresponding age control, although 
there was no significant difference detected between 
young and aged control animals (except for iron stain-
ing in basal ganglia which was considered separately). A 
p value ≤0.05 was considered as statistically significant. 
Statistical analyses were performed using PASW Statis-
tics 18 (SPSS Inc.).
Results
Microglial oxidative burst, oxidative damage and iron 
accumulation in multiple sclerosis
Active lesions in multiple sclerosis (MS) are associated 
with perivascular and parenchymal inflammation domi-
nated by CD8+ T cells [29]. Active demyelination and tis-
sue injury in acute or relapsing remitting MS occur at sites 
of massive microglial activation and macrophage infiltra-
tion with macrophages containing early myelin degradation 
products as defined by Brück et al. [10] (Fig. 1d inserts; see 
also supplementary information). In patients with primary 
or secondary progressive MS, slowly expanding active 
lesions defined by a small rim of microglial activation 
and macrophage infiltration at the edge of demyelinated 
plaques are prominent [45].
In order to study microglial and macrophage activa-
tion, we analysed the accumulation of p22phox, which is 
an essential subunit of NADPH oxidase complexes. Since 
there is currently no microglia-specific marker available, 
we distinguished microglia from macrophages by their 
morphological phenotype. Thus, our study does not allow 
conclusions, whether macrophages within the lesions were 
derived from the microglial cell pool or from recruited 
monocytes. Individual microglia in the human control brain 
moderately expressed p22phox (Fig. 1a; Table 2), whereas 
p22phox was distinctly present in microglial nodules in the 
normal-appearing white matter (NAWM) of MS patients 
(Fig. 1b) and in areas of initial tissue injury (pre-phago-
cytic lesions) [4, 25] (Fig. 1c). Compared with initial active 
lesions, p22phox expression was low in later stages of 
active or inactive lesion centres and solely present in cells 
with a macrophage phenotype (Fig. 1d). The expression of 
iNOS in different MS subgroups was described before [25, 
26]. We detected scattered microglia in the NAWM and in 
initial lesion areas expressing low levels of iNOS (Fig. 1e, 
f), whereas some microglia and macrophages in demyeli-
nated MS lesions showed prominent expression of iNOS 
[56] (Fig. 1g; Table 2). Nevertheless, iNOS staining was 
generally much lower compared with p22phox.
Oxidative burst activation in microglia and macrophages 
in active MS lesions was reported to be associated with the 
presence of oxidised phospholipids [25, 26, 33]. Only few 
cells containing oxidised lipids (e06 or MDA2 immunore-
activity) were found in the normal white matter (NWM) of 
controls (Fig. 1h) and in inactive lesions (not shown). The 
highest numbers of immunoreactive cells were detected in 
classical initial active lesions (Fig. 1i-l). In active lesions 
of the white and grey matter, oxidised lipids were found 
in oligodendrocytes and myelin (Fig. 1i, j), in cytoplasmic 
granules within astrocytes (Fig. 1k) as well as in dystrophic 
axons and degenerating neurons (Fig. 1l) [33].
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The liberation of iron from oligodendrocytes and mye-
lin in active MS lesions is a potential amplification fac-
tor for oxidative injury [35] (Fig. 1m–q). As described 
before [34, 35], iron accumulates during ageing within 
oligodendrocytes in the human brain (Fig. 1n, o). Addi-
tionally, some microglia in aged controls showed reac-
tivity for non-haeme iron [35]. In active MS lesions, 
iron-containing oligodendrocytes were lost and iron was 
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detected in the extracellular space [35]. Furthermore, iron 
within the lesions was taken up by microglia and mac-
rophages (Fig. 1p, q) and to a lower degree by astrocytes 
and axons [35] (not shown). Our findings on the expression 
of p22phox and iNOS and the occurrence of oxidised lipids 
(e06) in MS are summarised in Table 2.
The expression of genes related to oxidative stress, 
mitochondria and iron metabolism differs between passive 
transfer eAe and active white matter MS lesions
In recently published whole-genome microarray analyses, 
we have already shown profound changes in the expression 
of genes related to oxidative stress, mitochondrial injury 
and iron metabolism within active white and cortical grey 
matter MS lesions [25, 26]. In the present study, we ana-
lysed the expression of these candidate genes in the lower 
spinal cords of young (4 months) and aged (8 months) 
lewis rats suffering from MBP-specific CD4+ T cell-
induced eAe via rT-qPCr, and analysed them together 
with the microarray data from active MS white matter 
lesions (Fig. 2).
At both investigated eAe time points (day 6, eAe 
peak; day 10, recovery phase), we observed a massively 
upregulated expression of NADPH oxidase genes that 
was slightly damped in the older rat population (Fig. 2a). 
In contrast, the number of upregulated NADPH oxidase 
genes and the degree of upregulation differed markedly in 
active white matter MS lesions compared with eAe. iNOS 
(Nos2), a further initiator of oxidative/nitrative stress, was 
highly expressed in the acutely diseased rat spinal cords, 
whereas it was down-regulated in active white matter MS 
lesions. A high number of the mitochondrially encoded 
genes was at least twofold down-regulated in the MS 
lesions (Fig. 2c). In contrast, this pattern was not found in 
rat eAe tissue even at the peak of disease. regarding the 
expression of iron metabolism-related genes (Fig. 2b), the 
picture for many genes was mutually exclusive: if the gene 
expression was altered during eAe, either no or a contrary 
expression change was observed in the human MS tissue 
and vice versa.
Taken together, the comparison of rat eAe spinal cord 
tissue with human active white matter MS lesions revealed 
rather more differences than similarities in the expression 
patterns of genes related to oxidative stress, mitochondria 
and iron metabolism. Oxidative stress, presumably inflam-
mation induced, operates in both conditions studied. How-
ever, subsequent responses to oxidative damage and mito-
chondrial injury, as well as molecular changes regarding 
iron storage and release, seem to diverge.
To confirm these data on the basis of protein expression 
and to expand them to other models of inflammatory demy-
elination, we performed a detailed immunohistochemical 
analysis.
Microglial oxidative burst, oxidative injury and iron 
accumulation in various experimental models and MS 
patients diverge
EAE induced by passive transfer of MBP‑reactive T cells 
in Lewis rats
Passive transfer of encephalitogenic CD4+ T cells (Fig. 3a–
i) led to a monophasic acute inflammatory CNS disease, 
which started 3 days after T cell transfer, reached its peak 
after 6 days and was followed by a complete recovery of 
the animals [1]. The disease course was similar in young 
(2 months) and aged (14 months) animals when we trans-
ferred the same quantity of MBP-specific T cells (data not 
shown). At the peak of the disease, CNS lesions comprised 
pronounced T cell-mediated inflammation associated with 
microglia and macrophage activation and transient axonal 
dysfunction, but demyelination was sparse [1]. In compari-
son with young rats, the aged animals showed significantly 
lower numbers of infiltrating CD3+ T cells in the lumbar 
spinal cord (young 158.5 ± 97.8, old 58.4 ± 8.3 CD3+ 
T cells per mm2; p = 0.005) but similar areas covered by 
Fig. 1  Oxidative burst, oxidative injury and iron accumulation in MS 
lesions. expression of p22phox in the normal white matter (NWM) 
of a control brain (a), the normal-appearing white matter (NAWM; 
b), the zone of initial (pre-phagocytic) demyelination (c) and in 
the plaque centre of an active lesion (d) from an acute MS patient, 
defined by the presence of lFB and MOg reactive myelin degrada-
tion products in macrophages (inserts). Individual microglia in the 
control brain expressed p22phox. There was profound microglial 
activation in the NAWM with the formation of microglial nodules, a 
massive p22phox expression in initial areas of active demyelination 
and a low expression on macrophages containing myelin debris in the 
plaque centre. iNOS expression in acute MS in the NAWM (e) and 
in initial areas of demyelination (f) was weak and restricted to a few 
cells with microglial morphology. In the active plaque centre, iNOS 
was mainly expressed on macrophages (g). Immunoreactivity of e06 
staining for oxidised phospholipids was low or absent in the NWM of 
controls (h) and very high in areas of initial demyelination in acute 
MS (i). Double staining for e06 (blue) and cell markers (brown) doc-
umented its presence in oligodendrocytes (stained for TPPPp25; j) 
and cytoplasmic granules in astrocytes (stained for gFAP; k). Intense 
e06 reactivity was also found in the cytoplasm of cortical neurons, 
showing beading and fragmentation of their cell processes (l). Iron 
staining of the MS brain revealed profound iron accumulation in the 
subcortical white matter (m; arrowheads) and at the edge of active 
lesions (m; arrows) from a SPMS patient. established lesions showed 
a reduced iron staining (m; asterisks). Young control brains revealed a 
relatively low iron content mainly found in oligodendrocytes (n; age 
30). The aged human control (o; age 84) and MS (m; age 57) brains 
displayed high amounts of non-haeme iron in oligodendrocytes and 
myelin. High iron content was present at the edge of an active lesion 
from a rrMS patient in microglia (p). Within the centre of an active 
lesion, the iron load was reduced and iron reactivity was mainly 
found in (perivascular) macrophages (q). Scale bar 50 μm except for 
m = 1 cm
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eD1+ macrophages (young 10.4 ± 1.3 %, old 9.6 ± 3.9 %). 
Additionally, we detected a significantly higher number of 
amyloid precursor protein (APP)-positive axonal spheroids 
in the lesions of aged animals (young 43.5 ± 17.4, old 
58.5 ± 8.3 APP+ spheroids per mm2; p = 0.039), which 
indicated a higher level of acute axonal injury.
At the peak of the disease, p22phox and iNOS expres-
sions were low or absent in Iba-1+ cells with microglial 
morphology (Fig. 3a–c). However, we saw strong sig-
nals for p22phox and iNOS on cells with macrophage 
morphology in the lesions (Fig. 3b, c; Table 2). Further-
more, microglial nodules were completely absent from 
the NAWM. In the recovery phase of the disease, mac-
rophages expressed Iba-1 and the phagocytosis marker 
eD1 but had lost their p22phox and iNOS expressions 
(data not shown). Neither in young nor in aged animals 
was a specific staining for oxidised phospholipids detect-
able (Fig. 3d; Table 2). However, we found individual 
degenerating neurons in aged control and eAe rats that 
were specifically labelled for oxidised phospholip-
ids (Fig. 3e) confirming that we were able to detect the 
epitope of e06 in animals using the same staining proto-
col as for MS tissue.
We did not detect any iron accumulation in the normal-
appearing white and grey matter in young control animals 
(2–6 months; Fig. 3g; Table 2). In aged rats (14 months), 
minor iron accumulation was restricted to the basal gan-
glia (Fig. 3f), the substantia nigra and the dentate nucleus 
of the cerebellum. As in humans, iron in aged rats mainly 
accumulated within oligodendrocytes and rarely in micro-
glia (Fig. 3h). Within eAe lesions, individual iron-positive 
macrophages were found in the perivascular space (Fig. 3i).
Table 2  Quantification of markers for inflammation and oxidative injury in different experimental models for CNS inflammation and multiple 
sclerosis
Quantification of Iba-1, p22phox, iNOS, oxidised phospholipids (e06) and iron staining in active lesions of different rodent models for CNS 
inflammation in comparison with acute MS cases and human controls. Depicted are values of median (range) derived from optical densitometry 
(area fraction for Iba-1, p22phox, iNOS and iron and integrated density for e06) of equally sized pictures taken under standardised conditions of 
the respective animal model or MS case. Bold numbers indicate a significant increase compared to control animals, or in case of MS compared 
to human controls, using Mann–Whitney U post hoc tests and Bonferroni–Holm correction. In case of iron staining, lesions were compared with 
the respective control tissue
NWM normal white matter, NGM normal grey matter, EAE experimental autoimmune encephalomyelitis, pt passive transfer, BG basal ganglia, 
SC spinal cord, LPS lipopolysaccharide, n.p. not present, (young control animals n = 6; old control animals n = 6; acute eAe young n = 6; 
acute eAe aged n = 8; chronic MOg eAe mouse n = 15; chronic MOg eAe rat n = 14; CD8 eAe n = 6; lPS injection n = 20; cuprizone 
diet n = 5; coronavirus encephalomyelitis n = 11; acute MS n = 7; human controls n = 6)
a
 A significant increase compared to animal controls. Iron staining in basal ganglia (Bg) was significantly increased in old compared with 
young controls
b
 Iron accumulation in MS and human controls was not quantified in the present study, as it is dependent on location and age as described else-
where [35]
Model Mechanism Active lesion
Iba-1 p22phox iNOS e06 Iron
Acute pt eAe young CD4+ T cells 10.90 (5.23) 10.46 (3.66) 2.25 (2.10) 122 (44) 0.00 (0.01)
Acute pt eAe aged CD4+ T cells 8.59 (4.87) 9.10 (3.83) 2.99 (1.62) 130 (37) 0.00 (0.00)
Chronic MOg eAe mouse CD4+ T cells 11.12 (17.66) 3.28 (8.33) 0.02 (0.56) 185 (46) 0.18 (0.92)
Chronic MOg eAe rat CD4+ T cells + demyelinating 
antibodies
9.33 (16.18) 0.30 (3.90) 0.01 (0.06) 124 (172) 0.01 (0.73)
CD8 eAe CD8+ T cells 7.58 (7.42) 1.17 (2.53) 0.00 (0.31) 233 (97) 0.05 (0.32)
lPS injection Innate immunity 6.90 (17.30) 0.80 (3.70) 0.02 (0.86) 200 (35) 0.01 (1.00)
Cuprizone diet Toxic demyelination 11.97 (7.03) 0.04 (0.04) 0.00 (0.00) 130 (46) 0.01 (0.01)
Coronavirus MHV-JHM 
encephalomyelitis
Virus, CD8+ T cells,  
innate immunity
15.81 (13.16) 3.79 (4.73) 0.00 (0.09) 644 (138) 0.01 (0.70)
Acute MS Unknown 12.60 (18.86) 8.69 (12.12) 0.47 (2.58) 553 (313) b
NWM/NgM
Iba-1 p22phox iNOS e06 Iron
Bg SC
Young control animals n.p. 2.55 (1.69) 0.00 (0.01) 0.00 (0.00) 125 (48) 0.03 (0.04) 0.01 (0.02)
Old control animals n.p. 3.28 (2.98) 0.00 (0.01) 0.00 (0.00) 110 (39) 2.94 (2.08) 0.01 (0.02)
Human controls n.p. 4.41 (5.58) 2.47 (1.31)a 0.04 (0.02)a 336 (132)a b b
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Fig. 2  expression patterns of genes related to oxidative stress, mito-
chondria and iron metabolism differ between passive transfer eAe 
and active white matter MS lesions. The heat maps show colour‑
coded relative quantities of genes with known functions in oxidative 
stress pathways (a) and iron metabolism (b). Additionally, mito-
chondrially encoded genes (c) as well as nuclear-encoded genes with 
important mitochondrial functions (d) are depicted. The gene expres-
sion in lower spinal cords of young (4 months) and old (8 months) 
lewis rats suffering from MBP-specific T cell-induced eAe was 
determined at two time points (day 6, peak of disease; day 10, recov-
ery phase) via rT-qPCr. Transcriptional changes in periplaque 
white matter, initial (pre-phagocytic) lesions and active demyelinat-
ing lesions, derived from 3 or 4 acute MS cases, were investigated 
by whole-genome microarrays. relative quantities were calculated 
for each individual gene by comparing the different time points and 
lesions with untreated age-matched lewis rats or normal white matter 
from control cases, respectively. A detailed description of genes and 
primers/probes is presented in the supplementary data (Supplemen-
tary Table 3 and 4). d6 day 6, d10 day 10, PP periplaque white mat-
ter, I initial (pre-phagocytic) lesion, A active demyelinating lesion, 
n.d. not determined
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Chronic EAE induced in C57BL/6 mice by active 
immunisation with MOG35–55
Chronic eAe induced in C57BL/6 mice by active immuni-
sation with MOg35–55 peptide is currently the most widely 
used animal model in MS research. In this model, disease 
starts between 10 and 15 days after sensitisation with an 
acute disease episode, which is similar to the disease peak 
of acute T cell transfer eAe described above. In our model, 
this was followed by a variable and short remission and a 
relapse of the disease with a progressive increase of clini-
cal disease during the following weeks. Pathology in the 
relapsing/progressive stage of the disease is characterised 
by the presence of confluent inflammatory demyelinating 
lesions in the brain and spinal cord, associated with pro-
found axonal injury and destruction. For our study, we 
analysed animals with active demyelination and neuro-
degeneration 21, 27 and 35 days after immunisation [87]. 
Active tissue injury was associated with massive infiltration 
of the tissue by CD3+ T cells (Fig. 3j), profound microglia 
activation (Fig. 3k) and the presence of numerous mac-
rophages containing early myelin degradation products in 
the lesions (not shown). p22phox expression was restricted 
to cells with a macrophage-like morphology, while acti-
vated Iba-1 reactive microglia in the perilesional and nor-
mal-appearing white matter were negative and no microglia 
nodules were detected (Fig. 3l). Only single macrophage-
like cells also expressed iNOS (Fig. 3m; Table 2). A weak 
reactivity for oxidised phospholipids was seen occasionally 
in dystrophic axons (Fig. 3n; Table 2). We did not observe 
any iron accumulation in oligodendrocytes or myelin, but 
single iron-containing perivascular or meningeal mac-
rophages were detected in individual lesions (Fig. 3o; 
Table 2).
Chronic relapsing demyelinating EAE in DA rats
Active sensitisation of rats with MOg1-125 resulted in 
extensive primary inflammatory demyelination (Fig. 3p, 
t), which currently most closely reflects the pathology 
seen in multiple sclerosis [85]. In initial stages of active 
lesions (Fig. 3p), granulocytes and macrophages expressed 
p22phox (Fig. 3q) and few macrophages showed iNOS 
reactivity (Fig. 3r). In chronic active lesions (Fig. 3t), eD1+ 
macrophages or microglia (Fig. 3v) were largely negative 
for p22phox (Fig. 3u; Table 2) and iNOS (Fig. 3s; Table 2) 
despite massive on-going demyelination (Fig. 3t). Further-
more, microglial nodules in the NAWM were absent in all 
disease stages.
Similar to acute passive transfer eAe, animals suffering 
from chronic relapsing eAe did not show any accumula-
tion of oxidised phospholipids in active or inactive lesions 
(Fig. 3w; Table 2) with one exception. We observed small 
clusters of neurons in the spinal cord anterior horn showing 
reactivity for oxidised lipids and central chromatolysis in 
one individual animal out of 14 (Fig. 3w, insert). We could 
not detect any non-haeme iron staining in brain and spi-
nal cord tissue of control animals but most eAe animals 
showed iron accumulation in perivascular macrophages in 
the lesions (Fig. 3x; Table 2). We neither detected p22phox 
nor iNOS expression in chronic inactive demyelinated 
plaques in this model, nor did we observe immunoreactiv-
ity for oxidised phospholipids (data not shown).
Inflammatory demyelinating lesions induced by CD8+ 
cytotoxic T cells
Since inflammation in MS lesions is dominated by CD8+ 
T cells [2], we analysed oxidative injury in a CD8+ T 
Fig. 3  Oxidative burst, oxidative injury and iron accumulation in 
acute and chronic models of CD4+ T cell-mediated eAe. a–i Acute 
eAe induced by passive transfer of MBP-reactive encephalitogenic 
CD4+ T cells in aged lewis rats (14-month old) at the peak of the 
disease (6 days after T cell transfer). Inflammation was associated 
with profound microglial activation and macrophage infiltration at the 
lesions, immunoreactive for the pan-microglia/macrophage marker 
Iba-1 (a). In contrast, p22phox (b) and iNOS (c) expressions were 
more restricted and mainly found on cells with macrophage mor-
phology. No e06 reactivity (oxidised phospholipids) was detected 
in inflammatory lesions (d) but was occasionally found in degener-
ating neurons (for instance in the cerebellar cortex of an aged con-
trol rat; e). Iron accumulated in the basal ganglia of a 14-month old 
eAe rat (f) while it was absent from the basal ganglia of 2-month 
old rats (g). In old rats, iron accumulated in oligodendrocytes and 
myelin in the basal ganglia (h). Within inflammatory eAe lesions, 
few macrophages and microglia showed iron accumulation (i). j–o 
Chronic relapsing/progressive eAe in C57BL/6 mice immunised with 
MOg35–55. This model is characterised by large inflammatory demy-
elinating lesions with extensive axonal injury and loss in the spinal 
cord. The lesions contained abundant CD3+ T cells (j) and Iba-1+ 
macrophages (k). In addition, we found massive Iba-1 expression in 
cells with microglial morphology in the adjacent white and grey mat-
ter (k). The macrophages in the lesions also expressed p22phox (l), 
while iNOS expression was restricted to a limited number of perivas-
cular macrophages (m). e06 reactivity (oxidised phospholipids) was 
sparse or absent in the lesions (n), although there were few axonal 
spheroids with weak e06 staining (insert). Single lesion-associated 
meningeal macrophages accumulated iron (o). p–x Chronic relapsing 
eAe in DA rats immunised with MOg1–125. Initial lesions present-
ing with a perivenous pattern of demyelination (p) showed scattered 
p22phox (q) and iNOS (r) expressions. p22phox in these lesions was 
mainly seen in granulocytes (q, insert). In contrast, in the chronic 
phase of the disease, there was an extensively active demyelination 
in the spinal cord grey and white matter (t) indicated by the pres-
ence of macrophages with myelin degradation products (t, insert). 
The lesions contained high numbers of eD1+ macrophages (v) but 
their majority did not express p22phox (u) or iNOS (s). Only few 
macrophages in the lesions expressed p22phox (u, insert). Oxidised 
phospholipids did not accumulate in the active chronic lesions (w), 
but individual neurons with morphological evidence for retrograde 
degeneration were strongly labelled (w, insert). Within lesions, few 
macrophages and microglia showed iron accumulation (x). Scale bar 
50 μm except for f = 0.25 cm and j, k, n, o, p = 0.5 mm
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cell-driven model leading to confluent demyelinated 
lesions (Fig. 4a–f) [80]. Microglial activation was promi-
nent (Fig. 4a) but we could not detect any p22phox expres-
sion on microglia in the NAWM. In contrast, a substantial 
proportion of microglia as well as macrophages within and 
adjacent to lesions expressed p22phox (Fig. 4b; Table 2). 
iNOS reactivity was restricted to few perivascular mac-
rophages (Fig. 4c; Table 2). We did not observe any micro-
glia nodules in the NAWM (Fig. 4a). Also in this model, we 
did not find a significantly increased immunoreactivity for 
oxidised phospholipids in comparison to controls (Fig. 4d; 
Table 2). In the NAWM of the brain or the spinal cord as 
well as in the majority of active lesions, no iron accumula-
tion was present (Fig. 4e; Table 2) but we detected perivas-
cular macrophages with intense iron staining within single 
lesions in four out of seven animals studied (Fig. 4f).
Inflammatory demyelinating lesions induced by innate 
immunity
recent observations suggest a major role of innate immune 
mechanisms in the pathogenesis of MS [4, 56]. Hence, we 
studied inflammatory demyelinating lesions induced by 
focal injection of bacterial lPS into the spinal cord white 
matter of rats [21] (Fig. 4g–m). Inflammation started 8 h 
after lPS injection being dominated by p22phox+ granu-
locytes (Fig. 4g), which were replaced by p22phox+ 
macrophages on day 3 (not shown). As shown before, some 
macrophages and microglia at these early inflammatory 
stages expressed iNOS (Fig. 3h) [56]. Demyelination and 
axonal injury occurred 7–9 days after lPS injection and 
reached a peak after 12–15 days [21]. Iba-1 immunohisto-
chemistry showed densely packed macrophages within the 
demyelinating lesions (Fig. 4i). In actively demyelinating 
lesions, macrophages and few cells with microglia mor-
phology showed moderate p22phox expression (Fig. 4j; 
Table 2). We did not find any microglial nodules in the 
NAWM. Only individual microglia and macrophages dis-
played very faint reactivity for iNOS (Fig. 4k; Table 2). 
Immunohistochemistry for oxidised phospholipids revealed 
very weakly e06-positive myelin in the lesions at day 12 
(Fig. 4l; Table 2). Iron stainings were negative with the 
exception of some perivascular iron-positive macrophages 
in the lesions (Fig. 4m; Table 2).
Toxic demyelination induced by cuprizone diet
Demyelinating lesions in mice fed with cuprizone-sup-
plemented diet are regarded as a suitable model of demy-
elination in MS [41]. We analysed actively demyelinating 
lesions (Fig. 4n–s) showing oligodendrocyte apoptosis, 
microglial activation and astrocytic gliosis in the corpus 
callosum 35 days after disease induction [92]. The lesions 
contained densely packed Iba-1- and Mac-3-reactive cells 
with macrophage- or microglia-like morphology (Fig. 4o). 
However, the staining for p22phox was very faint (Fig. 4p; 
Table 2) and iNOS was only weakly expressed in single 
microglia (Fig. 4q; Table 2). Stainings for oxidised phos-
pholipids did not show increased immunoreactivity in com-
parison to controls (Fig. 4r; Table 2). Furthermore, no iron 
accumulation was detected in the brain or spinal cord of 
cuprizone-fed animals (Fig. 4s; Table 2).
Coronavirus‑induced inflammatory demyelination
Virus infections are suggested to be a causative factor in 
the development of MS [52]. We analysed brain lesions of 
lewis rats infected with mouse hepatitis virus leading to 
a complex immune response including CD8+ T cells [18, 
70] and specific anti-viral antibodies [51, 88, 97]. Intrac-
erebral MHV-JHM coronavirus injections [3, 44, 94, 97] 
resulted in a panencephalitis with profound brain inflam-
mation, global tissue damage and virus spread in neu-
rons and glia [44, 97]. This early phase was followed by 
a subacute or chronic phase, in which virus infection was 
mainly seen in glia associated with inflammatory demyeli-
nation in the brain and spinal cord (Fig. 5a-i) [44, 94, 97]. 
Inflammation was dominated by T cells (Fig. 5d), mainly 
CD8+ cells (Fig. 5i), and activated macrophages and 
microglia (Fig. 5j–n; Table 2). Microglial activation was 
Fig. 4  Oxidative burst, oxidative injury and iron accumulation in 
CD8+ T cell-mediated eAe, in innate immunity-driven inflammation 
and in toxic cuprizone-mediated demyelination. a–f Brain inflamma-
tion induced by CD8+ T cells. Perivascular inflammatory infiltrates 
were associated with massive microglial activation in the adjacent 
tissue (a; Iba-1). Perivascular inflammatory cells and to lower degree 
also the surrounding microglia highly expressed p22phox (b), while 
iNOS expression was minor and restricted to a few perivascular 
cells (c). The immunohistochemistry for oxidised phospholipids 
(e06; d) was negative. Iron deposition was lacking in most lesions 
(e) but occurred in few lesions within perivascular macrophages (f). 
g–m Inflammatory demyelinating lesions induced by local injec-
tion of lPS into the spinal cord dorsal column. In the early inflam-
matory stage (1 day after lPS injection), p22phox+ granulocytes (g) 
and iNOS+ macrophages (h) were present in the lesions. At the peak 
of active demyelination (9 days after lPS injection), lesions were 
densely infiltrated by macrophages and showed microglial activation 
at the lesion edge (i; Iba-1, asterisk). Macrophages in these lesions 
and, to a lower degree, microglia at the lesion edges showed expres-
sion of p22phox (j). Despite a very strong expression of p22phox in 
active lesions (j), the expression of iNOS was very low (k). There 
was a weak reactivity for oxidised phospholipids in the lesions (l; 
e06). Individual perivascular macrophages were iron positive (m). 
n–s Actively demyelinating lesion in the corpus callosum induced by 
cuprizone diet. extensive loss of myelin was seen in the corpus cal-
losum (n), which was densely packed with macrophages and micro-
glia (o), although their majority did not express p22phox (p) and 
iNOS only very weakly (q). Additionally, there was no evidence for 
oxidised phospholipids (r; e06) or iron deposition (s) in the lesions. 
Scale bar 50 μm
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profound throughout the brain and spinal cord in all dis-
ease stages [44, 97]. In contrast to all other models stud-
ied, we observed microglial nodules in the NAWM (Fig. 5j, 
k). The number of microglia increased towards the lesion 
edge (Fig. 5k, m, left side), showed the highest density at 
the zone of initial demyelination (Fig. 5k, m, middle) and 
decreased towards the centre of the lesion (Fig. 5k, m, right 
side), where many cells showed a macrophage morphology. 
Immunohistochemistry for p22phox in serial-cut adjacent 
sections revealed a staining pattern rather similar to that 
of Iba-1 in the NAWM (Fig. 5l) and the lesion (Fig. 5n; 
Table 2). p22phox expression was most profound in active 
lesions and the adjacent NAWM, while it was low on mac-
rophages in the inactive lesion centre (Fig. 5m, n). expres-
sion of iNOS was rare or absent and, if present, only found 
in individual macrophage-like cells (Fig. 5o; Table 2). 
Strikingly, we found intense staining for e06-positive oxi-
dised phospholipids within active lesions (Fig. 5p, q, s) and, 
to a lesser extent, in the NAWM. Additionally, we detected 
nuclear stainings of oxidised DNA in the lesions (Fig. 5r, 
8OHdg). Quantification of e06 immunohistochemistry by 
optical densitometry revealed a significantly higher den-
sity of e06 staining in coronavirus-induced lesions than in 
control rats (Table 2). Iron accumulation was restricted to 
perivascular macrophages within the lesions (Fig. 5t, u). 
Our observations describing p22phox and iNOS expres-
sions, detection of oxidised lipids (e06) and iron accumu-
lation in MHV-JHM coronavirus-induced inflammatory 
demyelination as well as the other rodent models are high-
lighted in Table 2.
Discussion
In the present study, we show notable differences between 
MS and its different animal models regarding microglial 
activation, oxidative injury and iron accumulation in the 
undiseased CNS as well as within active inflammatory 
demyelinating lesions (Table 2). We found that the expres-
sion of enzymes involved in oxygen and nitric oxide radi-
cal production in cells with microglia or macrophage 
phenotype is different depending on the primary nature 
of the inflammatory response. As shown before, enzymes 
implicated in oxygen and nitric oxide radical cascades are 
induced in the inflammatory infiltrates of CD4+ T cell-
mediated eAe [16, 43, 58, 78, 89, 90]. As observed in our 
study, they were mainly expressed in cells with macrophage 
morphology [63, 89]. Nitric oxide and its related reactive 
species in eAe lesions may serve anti-inflammatory func-
tions [6, 22, 79] or, in combination with oxygen radicals, 
may promote axonal injury [1, 13, 60] via the formation of 
peroxynitrite [9, 17]. We found that the above-mentioned 
macrophage and microglia activation patterns were differ-
ent in chronic CD4+ T cell-driven eAe and in models of 
CNS inflammation induced by CD8+ T cells or by innate 
immunity (lPS injection into the spinal cord white mat-
ter). In these situations at the time of active myelin destruc-
tion, NADPH oxidase subunit p22phox was mainly seen in 
macrophages, while iNOS expression was minor or absent. 
Furthermore, in active inflammatory demyelinating lesions 
induced by myelin-reactive antibodies or by the toxin cupri-
zone, very little expression of p22phox or iNOS was found, 
despite high expression of the phagocytosis-related mark-
ers eD1 (in rats) or Mac-3 (in mice). These findings were 
unexpected since pro-inflammatory cytokines, which are 
anticipated to be present in the lesions, evoked upregula-
tion of NADPH oxidase and iNOS expression in microglia 
in vitro [12, 49, 58]. Furthermore, iNOS expression in the 
model of MHV-JHM coronavirus-induced inflammatory 
demyelination was reported in infiltrating macrophages of 
acute lesions and astrocytes in chronic lesions [31]. How-
ever, we did not find any astrocytic staining in our experi-
mental setup. Our data support the view that the activa-
tion of microglia in a situation of an integrated immune 
response in vivo is more complex compared with the situ-
ation in vitro [5, 15, 76]. This possibly reflects the fact that 
Fig. 5  Oxidative burst, oxidative injury and iron accumulation in 
inflammatory demyelinating lesions in MHV-JHM coronavirus-
induced encephalomyelitis. a–i Basic characterisation of inflamma-
tory demyelinating lesions in the spinal cord of an infected lewis 
rat with demyelinating encephalomyelitis after infection with MHV-
JHM coronavirus. There was extensive plaque-like demyelination (a; 
MBP) with relative preservation of axons (b and f; e NAWM; Bodian 
silver impregnation). Virus antigen was present in the periplaque 
white and grey matter (c; immunohistochemistry for nucleocapsid 
protein N) in neurons (g) as well as in glia cells in the white mat-
ter (h). Active demyelination was associated with profound T cell-
mediated inflammation (d), the majority of inflammatory cells being 
CD8+ T cells (blue; i) and eD1+ macrophages (brown; i). j–n Deter-
mination of microglial activation in MHV-JHM coronavirus-induced 
lesions. Activated microglia formed microglial nodules in the NAWM 
reactive for Iba-1 (j) and p22phox (l). The edge of an active lesion 
is shown with immunocytochemistry for macrophages/microglia (Iba-
1; k), for myelin (MBP; m) and for expression of NADPH oxidase 
(p22phox; n). Active demyelination was associated with profound 
microglial activation (k; Iba-1). Their numbers increased in the peri-
plaque white matter (PPWM) towards the lesion edge (k; left side) 
showing the highest density at the zone of initial demyelination (k, 
middle) and decreasing towards the centre of the lesion, where many 
cells exhibited a macrophage phenotype (k; right side). Immunohisto-
chemistry for p22phox in serial-cut adjacent sections from the lesion 
(n) showed a staining pattern similar to that of Iba-1. iNOS expres-
sion was sparse in the lesions (o). p–u Accumulation of oxidative 
damage and iron in MHV-JHM coronavirus-induced lesions. lesions 
showed abundant reactivity for oxidised phospholipids (p, q, s e06) 
in myelin (p), in cells with apoptotic nuclei (q), in macrophage gran-
ules (q) and in axonal spheroids (s). In addition, nuclei within the 
lesions contained oxidised DNA (8OHdH reactivity; r). Most lesions 
did not show iron deposition (t), although iron-positive perivascular 
macrophages accumulated in individual lesions (u). Scale bar 50 μm 
except for a–d = 0.5 mm
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the induction of NADPH oxidases is regulated by multiple 
additional factors such as Toll-like receptor activation [50], 
certain putative anti-inflammatory cytokines [61, 65, 66], 
cholesterol load [75], thrombin [14], divalent cations [37, 
40] and intracellular sodium accumulation [39]. All these 
factors are likely to contribute to a complex inflammatory 
process like that present in MS.
Oxidative injury and mitochondrial damage have been 
shown to play a role in neurodegeneration in eAe. Treat-
ments targeting oxidative injury or protecting mitochon-
dria were shown to be beneficial [27, 55, 62, 73, 83]. The 
presence of antibodies recognising oxidised phospholipids 
was demonstrated in MS and eAe [74]. In contrast, there 
are also antioxidant treatments that failed to attenuate eAe 
[24]. Both the presence of oxidised lipids and proteins as 
well as of antibodies against oxidised epitopes may have 
pro- and anti-inflammatory properties [19, 20, 23, 74].
The lack of accumulation of oxidised phospholipids pre-
sented in our study does not exclude oxidative injury in the 
respective models. Our data, however, show a major quan-
titative difference in the extent of oxidative injury between 
MS lesions and the majority of the studied experimental 
models of CNS inflammation and demyelination. Several 
possible explanations may serve as the basis for this obser-
vation. In the normal human brain, there is already moder-
ate expression of NADPH oxidases and iNOS in microglia, 
which is absent in rodents. In contrast to humans, experi-
mental animals are housed under highly standardised con-
ditions and, therefore, peripheral immune stimulation due 
to infections is unlikely [68]. Furthermore, microglial acti-
vation occurs in the human brain as an age-related process 
[53, 86]. In addition, factors related to ageing as well as 
the accumulation of lesion burden may amplify oxidative 
injury in the CNS of MS patients. One of these possible 
factors could be iron accumulation in oligodendrocytes and 
myelin, which occurs in humans during ageing [34]. Iron is 
suggested to promote oxidative injury when liberated from 
degenerating oligodendrocytes or myelin during demy-
elination [35]. Our study shows that iron accumulation in 
oligodendrocytes and myelin in the brain occurs only to a 
moderate degree in aged rodents and, if present at all, is 
restricted to the brain stem nuclei. Thus, the age-dependent 
physiological iron accumulation in the human brain is only 
poorly reflected in the normal rodent brain. This may relate 
to the much shorter life span of the animals. When the iron 
load in the rodent CNS is increased by knockout of a gene 
associated with iron detoxification and mobilisation (ceru-
loplasmin), traumatic spinal cord injury leads to increased 
free radical-mediated damage, impaired functional recov-
ery and increased neurodegeneration [77]. Animals with 
dysfunctional hephaestin, a molecule involved in iron 
efflux, show deficits in motor performance with age [82]. 
In the course of brain inflammation, however, we found 
iron accumulation in macrophages possibly due to leak-
age of blood in active inflammatory lesions [28]. Moreo-
ver, iron chelator treatments of animals suffering from eAe 
ameliorate the disease [7, 48, 59, 67]. This may be due to 
a decrease of oxidative stress and an inhibition of immune 
cell proliferation [59]. However, it is important to note that 
the iron load in the brain parenchyma of humans is remark-
ably higher than that of animals and likewise the resulting 
oxidative stress.
Furthermore, the accumulation of lesional burden in 
chronic diseases may play a role in the induction or propa-
gation of lesions. Chronic pro-inflammatory microglial 
activation may be further amplified by retrograde degenera-
tion due to distant chronic lesions with axonal and neuronal 
loss. Indeed, a recent neuropathological study suggests that 
cortical areas in the MS brain, which are connected with 
distant lesion sites, are more likely to develop new demy-
elinating lesions than other cortical regions [42]. However, 
extensive demyelination, axonal loss and retrograde degen-
eration, which are present in chronic eAe in DA rats [85], 
did not lead to oxidative burst activation in the normal-
appearing grey and white matter.
The only experimental model, in which we found an 
accumulation of oxidised phospholipids to an extent similar 
to that in MS patients, was the chronic inflammatory demy-
elination induced by brain infection with the MHV-JHM 
coronavirus. This model shares several features with MS. It 
is a chronic progressive inflammatory disease of the CNS, 
which leads to large plaques of primary demyelination with 
variable axonal loss and diffuse neurodegeneration in the 
NAWM [3, 97]. As in MS, inflammation is dominated by 
CD8+ T cells [18, 70] with profound microglial and mac-
rophage activation [96] and clusters of activated microglia 
(microglial nodules) in the NAWM, which are highly char-
acteristic of MS pathology [4, 72, 91]. Mechanisms of tis-
sue injury in this model are apparently complex involving 
CD8+ and CD4+ T cells [18, 36, 69, 70, 84] and specific 
anti-viral antibodies [51, 88, 97]. In addition, chronic per-
sistent virus infection in the CNS may provide an additional 
stimulus for microglial activation through Toll-like recep-
tors. Whether the extensive oxidative injury found in MHV-
JHM coronavirus-induced encephalomyelitis is also present 
in other virus-induced models of chronic inflammatory 
demyelinating disease, such as Theiler’s murine encepha-
lomyelitis virus (TMeV) or canine distemper virus-induced 
encephalomyelitis, or is a specific feature of the MHV-JHM 
coronavirus-induced disease awaits further investigation. 
The chronicity of the inflammatory stimulus present in the 
MHV-JHM coronavirus model may be one factor that lends 
similarity of the pathology with that of MS.
We think that our findings may have major implications 
for the development of new therapeutic strategies for MS. 
Due to the notable differences observed in the mechanisms 
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and extent of tissue injury between MS and current eAe 
models, the testing of neuroprotective treatments in eAe 
may not provide the answers necessary for predicting the 
outcome in patients. As an example, therapies aiming at 
stimulating endogenous antioxidant defence mechanisms, 
for instance by inducing the Nrf2 pathway [81], may be 
quite effective in a situation of moderate oxidative stress 
such as the one in classical eAe models. However, they 
might be ineffective or even counterproductive when oxi-
dative injury is very extensive and endogenous defence 
mechanisms may have already reached a plateau. Thus, it 
will be important to create new experimental models that 
mimic the oxidative damage in MS more closely than those 
currently available. Chronic viral models of inflamma-
tory demyelination may be more suitable. In addition, we 
encourage that transgenic animals over-expressing NADPH 
oxidases in microglia, with pre-existing defects in mito-
chondrial function or with an excessive brain iron load, 
should be developed. However, most important may be the 
chronicity of a sustained and severe inflammatory stimulus. 
This may finally result in cumulative effects of oxidative 
damage, which may trigger or become amplified by mul-
tiple factors, such as chronic microglia activation, oxygen 
radical production by injured mitochondria [11] as well as 
by age-dependent iron accumulation in the prime targets of 
MS tissue damage, the oligodendrocytes and myelin [35].
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